End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
156.5 TWD | +0.32% | +0.97% | +0.32% |
02-27 | Grape King Bio Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-09 | Grape King Bio Hits Record-High Sales of NT$10.64 Billion in 2023 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- This company will be of major interest to investors in search of a high dividend stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.32% | 711M | - | ||
+8.20% | 7.78B | D+ | ||
+10.20% | 6.52B | - | ||
-8.10% | 3.67B | D | ||
-13.13% | 3.44B | B- | ||
-14.57% | 1.17B | - | - | |
+8.34% | 934M | - | ||
-42.27% | 879M | B+ | ||
-18.90% | 836M | C+ | ||
-16.45% | 802M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 1707 Stock
- Ratings Grape King Bio Ltd